跳至主要内容
临床试验/NL-OMON39400
NL-OMON39400撤回不适用

Treatment of Central Sleep Apnea Syndrome with low-pressure nasal continuous positive airway pressure and rebreathing. - CSAS treated with rebreathing and nCPAP.

Medisch Centrum Alkmaar0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • outpatients diagnosed with central sleep apnea syndrome by polysomnography with sleep apnea index *15 and at least 50% of all apneas is central in origin without obstructieve components.
  • Age 18-80 years
  • Patients are using or have been using CPAP.
  • Informed Consent

排除标准

  • History of heart failure, cardiac arrhythmia or cardiac ischemia,
  • History of stroke
  • Cheyne Stokes breathing during daytime,
  • Sedatives or hypnotic agents, opioids.,
  • Respiratory failure( hypoxia, hypercapnia or respiratory acidosis during daytime)
  • Pulmonary diseases
  • Body mass index * 30
  • Untreated thyroid disease

研究者

发起方
Medisch Centrum Alkmaar

相似试验